← Eichor
Condition: Hematologic Tests Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hematologic Tests

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Pr
Phase 4 · 2 location(s) · Sanofi · NCT06145373Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT07399977Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute M
Phase 1 · 22 location(s) · National Cancer Institute (NCI) · NCT06484062Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Scr
NA · 3 location(s) · Centre Hospitalier Universitaire de Besancon · NCT04767568LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
Phase N/A · 8 location(s) · Centre Leon Berard · NCT02511288Early Intervention in High Risk CCUS
EARLY_Phase 1 · 1 location(s) · Lachelle D. Weeks, MD, PhD · NCT06802146Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Mod
Phase N/A · 8 location(s) · Bristol-Myers Squibb · NCT06357754Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Le
Phase 2 · 8 location(s) · National Cancer Institute (NCI) · NCT07061951Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
NA · 1 location(s) · Washington University School of Medicine · NCT06340646Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
Phase N/A · 1 location(s) · Children's Hospital of Philadelphia · NCT06389994Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
Phase 2 · 1 location(s) · UNICANCER · NCT06450314Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
Phase N/A · 9 location(s) · ADVANCED MARKER DISCOVERY S.L. · NCT06889883The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in
NA · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07027826Clinical Validation of a Predictive Test for Postpartum Depression
Phase N/A · 2 location(s) · University of Virginia · NCT06831968Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT06907797Caris Chromoseq Data Collection
Phase N/A · 1 location(s) · Caris Science, Inc. · NCT07680868Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery
NA · 3 location(s) · Konkuk University Medical Center · NCT05806346Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
Phase N/A · 5 location(s) · ADVANCED MARKER DISCOVERY S.L. · NCT06889844Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening
Phase N/A · 4 location(s) · Syantra Inc. · NCT07219277Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Phase 1 · 14 location(s) · National Cancer Institute (NCI) · NCT06465316Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation
Phase 1 · 1 location(s) · Nantes University Hospital · NCT04180059EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection
NA · 2 location(s) · Queensland Centre for Gynaecological Cancer · NCT07491081Validating a Blood Test for the Detection of Traumatic Brain Injury in Children
Phase N/A · 1 location(s) · University of Nebraska · NCT06940232Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual C
Phase 2 · 113 location(s) · National Cancer Institute (NCI) · NCT06317662Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Specimens
NA · 3 location(s) · Abbott Point of Care · NCT07287618Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · 631 location(s) · National Cancer Institute (NCI) · NCT04269902Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery
Phase 4 · 1 location(s) · Konkuk University Medical Center · NCT06144125Myeloma Registry Platform (MYRIAM)
Phase N/A · 1 location(s) · iOMEDICO AG · NCT03308474Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
NA · 1 location(s) · Hasselt University · NCT07087080Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling,
Phase N/A · 28 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05772559
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.